Genomma Lab Internacional SAB de CV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MX01LA010006
MXN
18.02
17.14 (1947.73%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
4,676.44
4,406.33
4,665.57
5,092.51
4,651.49
4,197.32
3,524.74
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,676.44
4,406.33
4,665.57
5,092.51
4,651.49
4,197.32
3,524.74
Raw Material Cost
1,707.02
1,639.01
1,723.90
1,820.51
1,673.80
1,457.65
1,412.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
257.33
270.57
434.11
310.31
278.33
228.33
377.44
Selling and Distribution Expenses
1,965.76
1,807.86
1,949.96
2,160.05
2,000.82
1,884.22
1,371.70
Other Expenses
-25.73
-27.06
-43.41
-31.03
-27.83
-22.83
-37.74
Total Expenditure (Excl Depreciation)
3,672.78
3,446.86
3,673.87
3,980.56
3,674.62
3,341.87
2,784.12
Operating Profit (PBDIT) excl Other Income
1003.7
959.5
991.7
1112
976.9
855.5
740.6
Other Income
-189.48
12.28
41.55
130.62
144.13
-50.13
-289.56
Operating Profit (PBDIT)
906.21
1,068.76
1,154.45
1,331.10
1,180.85
895.34
532.29
Interest
257.33
270.57
434.11
310.31
278.33
228.33
377.44
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,969.41
2,767.32
2,941.67
3,272.00
2,977.70
2,739.67
2,112.32
Depreciation
92.04
97.02
121.19
88.53
59.84
90.02
81.23
Profit Before Tax
556.84
701.17
599.15
932.26
842.67
576.99
73.62
Tax
201.87
202.45
125.66
272.20
211.03
144.90
186.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
354.97
498.72
473.49
660.06
631.64
372.11
-115.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
354.97
498.72
473.49
660.06
631.64
372.11
-115.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
354.97
498.72
473.49
660.06
631.64
372.11
-115.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,235.39
11,108.86
10,884.86
11,153.04
10,578.20
9,774.07
9,441.35
Earnings per share (EPS)
0.36
0.51
0.48
0.7
0.67
0.39
-0.12
Diluted Earnings per share
0.36
0.51
0.48
0.7
0.67
0.39
-0.12
Operating Profit Margin (Excl OI)
21.46%
21.77%
21.26%
21.84%
21.0%
20.38%
21.01%
Gross Profit Margin
13.88%
18.11%
15.44%
20.04%
19.4%
15.89%
4.39%
PAT Margin
7.59%
11.32%
10.15%
12.96%
13.58%
8.87%
-3.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 6.13% vs -5.56% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -28.81% vs 5.32% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 3.71% vs -5.07% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -4.92% vs -37.66% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Genomma Lab Internacional SAB de CV With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(MXN)
Change(%)
Net Sales
4,676.44
0
4,676.44
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,676.44
0
4,676.44
Raw Material Cost
1,707.02
0
1,707.02
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
257.33
0
257.33
Selling and Distribution Expenses
1,965.76
0
1,965.76
Other Expenses
-25.73
0.00
-25.73
Total Expenditure (Excl Depreciation)
3,672.78
0
3,672.78
Operating Profit (PBDIT) excl Other Income
1,003.65
0.00
1,003.65
Other Income
-189.48
0
-189.48
Operating Profit (PBDIT)
906.21
0
906.21
Interest
257.33
0
257.33
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
2,969.41
0
2,969.41
Depreciation
92.04
0
92.04
Profit Before Tax
556.84
0
556.84
Tax
201.87
0
201.87
Provisions and contingencies
0
0
0.00
Profit After Tax
354.97
0
354.97
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
354.97
0
354.97
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
354.97
0
354.97
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
11,235.39
0
11,235.39
Earnings per share (EPS)
0.36
0
0.36
Diluted Earnings per share
0.36
0
0.36
Operating Profit Margin (Excl OI)
21.46%
0%
0.00
21.46%
Gross Profit Margin
13.88%
0%
0.00
13.88%
PAT Margin
7.59%
0%
0.00
7.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 467.64 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 6.13% vs -5.56% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.54% vs 6.43% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 35.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -28.81% vs 5.32% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -43.79% vs 51.32% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 109.57 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.71% vs -5.07% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 5.69% vs 17.63% in Jun 2024

Quarterly - Interest
Interest 25.73 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -4.92% vs -37.66% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -7.55% vs 37.91% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.46%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024